share_log

Roth MKM Reiterates Buy on BioRestorative Therapies, Maintains $15 Price Target

Benzinga ·  Aug 14, 2023 21:51

Roth MKM analyst Jonathan Aschoff reiterates BioRestorative Therapies (NASDAQ:BRTX) with a Buy and maintains $15 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment